SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-17-008551
Filing Date
2017-09-19
Accepted
2017-09-19 08:01:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G stetson13g_sep2017.htm SC 13G 98216
  Complete submission text file 0001654954-17-008551.txt   99586
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60385 | Film No.: 171091097
SIC: 2834 Pharmaceutical Preparations

Mailing Address 347 N. NEW RIVER DRIVE EAST #2904 FORT LAUDERDALE FL 33301
Business Address
Stetson John (Filed by) CIK: 0001553316 (see all company filings)

Type: SC 13G